Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Stephan

Showing results (161-170 of 222) with videos related to

Pageof 23
Sort By:
Anticancer Research|January 25, 2008
Transrectal broadband-Doppler sonography with intravenous contrast medium administration for prostate imaging and biopsy in men with an elevated PSA value and previous negative biopsiesKasra Taymoorian, Anke Thomas, Torsten Slowinski, et al.
Clinical Chemistry|January 15, 2005
Intron retention: a common splicing event within the human kallikrein gene familyIacovos P Michael, Lisa Kurlender, Nader Memari, et al.
Oncotarget|November 2, 2017
Loss of cadherin related family member 5 (CDHR5) expression in clear cell renal cell carcinoma is a prognostic marker of disease progressionFelix Marius Bläsius, Sebastian Meller, Carsten Stephan, et al.
Urologic Oncology|April 6, 2010
Outcome prediction for prostate cancer detection rate with artificial neural network (ANN) in daily routineThorsten H Ecke, Peter Bartel, Steffen Hallmann, et al.
International Journal of Cancer|August 14, 2009
Diagnostic and prognostic implications of microRNA profiling in prostate carcinomaAnnika Schaefer, Monika Jung, Hans-Joachim Mollenkopf, et al.
BJU International|February 27, 2016
Significant reduction in positive surgical margin rate after laparoscopic radical prostatectomy by application of the modified surgical margin recommendations of the 2009 International Society of Urological Pathology consensusAndreas Maxeiner, Ahmed Magheli, Korinna Jöhrens, et al.
Clinical Chemistry|July 27, 2002
Multicenter evaluation of an artificial neural network to increase the prostate cancer detection rate and reduce unnecessary biopsiesCarsten Stephan, Henning Cammann, Axel Semjonow, et al.
Histology and Histopathology|September 8, 2025
CD63 is a diagnostic marker of prostate cancer and a prognostic marker of biochemical progression following radical prostatectomyElisabeth Dingendorf, Marit Bernhardt, Isabella Federica Bollen, et al.
Anticancer Research|August 5, 2003
mRNA expression profile of matrix metalloproteinases and their tissue inhibitors in malignant and non-malignant prostatic tissueRalf Lichtinghagen, Petra B Musholt, Carsten Stephan, et al.
The Prostate|July 15, 2003
Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissuesGeorge M Yousef, Carsten Stephan, Andreas Scorilas, et al.
Pageof 23

Showing results (161-170 of 222) with videos related to

Sort By:
Pageof 23
Anticancer Research|January 25, 2008
Transrectal broadband-Doppler sonography with intravenous contrast medium administration for prostate imaging and biopsy in men with an elevated PSA value and previous negative biopsiesKasra Taymoorian, Anke Thomas, Torsten Slowinski, et al.
Clinical Chemistry|January 15, 2005
Intron retention: a common splicing event within the human kallikrein gene familyIacovos P Michael, Lisa Kurlender, Nader Memari, et al.
Oncotarget|November 2, 2017
Loss of cadherin related family member 5 (CDHR5) expression in clear cell renal cell carcinoma is a prognostic marker of disease progressionFelix Marius Bläsius, Sebastian Meller, Carsten Stephan, et al.
Urologic Oncology|April 6, 2010
Outcome prediction for prostate cancer detection rate with artificial neural network (ANN) in daily routineThorsten H Ecke, Peter Bartel, Steffen Hallmann, et al.
International Journal of Cancer|August 14, 2009
Diagnostic and prognostic implications of microRNA profiling in prostate carcinomaAnnika Schaefer, Monika Jung, Hans-Joachim Mollenkopf, et al.
BJU International|February 27, 2016
Significant reduction in positive surgical margin rate after laparoscopic radical prostatectomy by application of the modified surgical margin recommendations of the 2009 International Society of Urological Pathology consensusAndreas Maxeiner, Ahmed Magheli, Korinna Jöhrens, et al.
Clinical Chemistry|July 27, 2002
Multicenter evaluation of an artificial neural network to increase the prostate cancer detection rate and reduce unnecessary biopsiesCarsten Stephan, Henning Cammann, Axel Semjonow, et al.
Histology and Histopathology|September 8, 2025
CD63 is a diagnostic marker of prostate cancer and a prognostic marker of biochemical progression following radical prostatectomyElisabeth Dingendorf, Marit Bernhardt, Isabella Federica Bollen, et al.
Anticancer Research|August 5, 2003
mRNA expression profile of matrix metalloproteinases and their tissue inhibitors in malignant and non-malignant prostatic tissueRalf Lichtinghagen, Petra B Musholt, Carsten Stephan, et al.
The Prostate|July 15, 2003
Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissuesGeorge M Yousef, Carsten Stephan, Andreas Scorilas, et al.
Pageof 23